Aptar PharmaProduct InfoAptar Pharma Launches First Metal-Free Highly Recyclable Nasal Spray PumpAptar Pharma announces the launch of APF Futurity, its first metal-free, multidose nasal spray pump ...
Aptar PharmaBrand LaunchAptar Pharma granted exclusive license option by Pharmaxis to develop and promote high payload dry powder inhalerAptar Pharma have entered into an agreement with Pharmaxis, a clinical stage drug developer, under w...
Aptar PharmaCompany NewsAptar Pharma Announces Collaboration with TFF PharmaceuticalsAptar Pharma announces collaboration with TFF Pharmaceuticals to develop intranasal delivery of dry ...
Aptar PharmaProduct InfoFirst Nasally-Administered Pharmaceutical Treatment for Dry Eye Disease Approved by US FDA with Aptar’s Nasal Pump SystemAptar Pharma’s patented Cartridge Pump System (CPS), was recently reviewed by the U.S. FDA as the dr...
Aptar PharmaYouTube VideoAptar Pharma PremiumCoat: Accelerating & derisking injectable drug developmentDiscover PremiumCoat, Aptar Pharma’s ETFE film-coated platform of vial stoppers, syringe components ...
Aptar PharmaProduct InfoAptar Pharma highlights expanded services platformAptar Pharma is highlighting its diverse portfolio of drug delivery systems, components and active p...
Aptar PharmaProduct InfoNoble and Aptar Pharma launch AdhereIT, a connected medical device solution for disease management adherence and onboarding patientsNoble and Aptar Pharma are pleased to announce the launch of AdhereIT - a connected, intuitive and u...
Aptar PharmaProduct InfoAptar Pharma Launches HeroTracker SenseAptar Pharma, a global leader in drug delivery systems, services and active material science solutio...
Aptar PharmaBrand LaunchNew FDA approved combination product with Aptar Pharma's VP3 nasal spray systemAptar Pharma, a global leader in drug delivery systems, services and active material science solutio...
Aptar PharmaCompany NewsAptar Pharma to host live webinar on decoding the FDA's recent combination drug product guidanceAptar Pharma, a leading drug delivery systems provider, will host a live webinar on September 18, 20...
Aptar PharmaCompany News Aptar Pharma's Preservative-Free Multidose Dispenser approved for anti-allergy treatment by French regulatory agency ANSMAptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the approved ...
Aptar PharmaProduct InfoAptar Pharma's nasal unidose device approved for Tosymra sumatriptan sprayAptar Pharma, a leading provider of drug delivery devices worldwide and part of AptarGroup, Inc. has...
Aptar PharmaProduct InfoAptar’s Nasal Unidose Device approved by US FDAAptarGroup, Inc, a global leader in dispensing and drug delivery solutions, has announced that its U...
Aptar PharmaYouTube VideoAptar Pharma - Improving Lives, Helping Customers SucceedAptar Pharma is a leading provider of innovative drug delivery systems for the world’s biggest brand...
Aptar PharmaCompany NewsAptar Pharma and RDD Online co-organize the second edition of RDD ASIA in Goa, IndiaAptar Pharma and RDD Online today announced the second Respiratory Drug Delivery (RDD®) Asia scienti...
Aptar PharmaCompany NewsAptar Pharma's Freepod nasal spray device with GlaxoSmithKline's Otrivin wins prestigious WPO WorldStar 2019 awardAptar Pharma, a leading provider of innovative drug delivery systems, has announced that its patente...
Aptar PharmaCompany NewsAptar Pharma's bidose nasal drug delivery device approved by US FDA for breakthrough treatment of depressionAptar Pharma, a leading drug delivery systems provider, has announced that its Bidose nasal spray de...
Aptar PharmaProduct InfoAptar Pharma's electronic lockout device approved by EMAAptar Pharma, a world leader in innovative drug delivery systems, is pleased to announce the approva...
Aptar PharmaProduct InfoAptar Pharma provides unit-dose nasal spray technology for treatment of opioid overdoseAptar Pharma has announced that it has provided the delivery system and regulatory support for Adap...
.jpg)
.jpg)
.jpg)
